Laboratoire Francais du Fractionnement et des Biotechnologies Sustainability Reports

A biopharmaceutical company specializing in the development, production, and marketing of plasma-derived medicinal products and recombinant proteins. Its therapies target serious and rare diseases across immunology, intensive care, and hemostasis.

Sector: Professional & technical services

Country: France

Exchange: Unlisted

LEI: 969500W3S73ZWL7HPC72

6 reports from 2023 to 2026

• Laboratoire Francais du Fractionnement et des Biotechnologies 2026 Health and Safety Policy
• Laboratoire Francais du Fractionnement et des Biotechnologies 2025 Modern Slavery Statement
• Laboratoire Francais du Fractionnement et des Biotechnologies 2025 CSR Report
• Laboratoire Francais du Fractionnement et des Biotechnologies 2024 Non-Financial Performance Statement
• Laboratoire Francais du Fractionnement et des Biotechnologies 2024 Non-Financial Performance Statement